Drug Chatter -- Tracking biopharma stock chatter

💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…

Profile for Kamada Ltd. (KMDA)

« Back to company index

KMDA Chatter Timeline

Stock Ticker for KMDA

Most Active Tweeters for KMDA

UserTweets
@newsfilterio 2
@MarcJacksonLA 2
@sbwcws 1
@otcdynamics 1
@StockNewsNow 1

Recent Tweets for KMDA

nk3901 @nk3901
@ZeContrarian7 any update on $kmda - I am long on this :)
April 13th 2021, 2:04am
moneymessage_ @moneymessage_
$KMDA $TAK - Kamada says amendment to Takeda deal could accelerate payments https://t.co/IrGenSCKnk
April 8th 2021, 9:04am
newsfilterio @newsfilterio
Kamada Announces Amendment to GLASSIA® License Agreement with Takeda $KMDA https://t.co/gMWntzdGpV
April 8th 2021, 8:04am
BeefEnt @BeefEnt
RT @StockNewsNow: $KMDA Kamada Announces Amendment to GLASSIA® License Agreement with Takeda https://t.co/TnJFes1N6J
April 7th 2021, 9:04pm
StockNewsNow @StockNewsNow
$KMDA Kamada Announces Amendment to GLASSIA® License Agreement with Takeda https://t.co/TnJFes1N6J
April 7th 2021, 8:04pm
MarcJacksonLA @MarcJacksonLA
$KMDA $TAK Kamada Announces Amendment to GLASSIA® License Agreement with Takeda https://t.co/iAen4e3qFg
April 7th 2021, 8:04pm
newsfilterio @newsfilterio
Kamada says amendment to Takeda deal could accelerate payments $KMDA https://t.co/JP1f9O4y6h
April 7th 2021, 8:04pm
glitchbotio @glitchbotio
RT @MarketCurrents: $KMDA $TAK - Kamada says amendment to Takeda deal could accelerate payments https://t.co/qBMDtk1E8G
April 7th 2021, 7:04pm
MarketCurrents @MarketCurrents
$KMDA $TAK - Kamada says amendment to Takeda deal could accelerate payments https://t.co/qBMDtk1E8G
April 7th 2021, 7:04pm
SmallCapsDaily @SmallCapsDaily
$KMDA Kamada Announces Amendment to GLASSIA® License Agreement with Takeda GlobeNewswire https://t.co/6M23AJ3neN… https://t.co/A07LKD138R
April 7th 2021, 3:04pm
MarcJacksonLA @MarcJacksonLA
$KMDA Kamada Announces Amendment to GLASSIA® License Agreement with Takeda https://t.co/iAen4e3qFg
April 7th 2021, 2:04pm
NewsQuantified @NewsQuantified
$KMDA Announces Amendment to GLASSIA® License Agreement with Takeda. Stock rockets +9.15% https://t.co/oaJsElQchk
April 7th 2021, 12:04pm
otcdynamics @otcdynamics
$KMDA Kamada Announces Amendment to GLASSIA® License Agreement with Takeda https://t.co/wyQn1kW2Cn
April 7th 2021, 11:04am
sbwcws @sbwcws
Kamada announces amendment to GLASSIA license agreement with Takeda $KMDA $TAK
April 7th 2021, 11:04am
EdgarInsider @EdgarInsider
FORM 6-K recently SEC filed. $KMDA #Kamada Ltd https://t.co/rLnpqlpKkY
April 7th 2021, 11:04am
bthefirsttoknow @bthefirsttoknow
$KMDA.TA $KMDA Kamada Announces Amendment to GLASSIA License Agreement with Takeda https://t.co/2M57NVMIkA
April 7th 2021, 11:04am
stock_titan @stock_titan
$KMDA Kamada Announces Amendment to GLASSIA® License Agreement with Takeda https://t.co/0sKICYz1wW
April 7th 2021, 11:04am
StockNewsNow @StockNewsNow
$KMDA Kamada Announces Top-line Results from its Phase 1/2 Clinical Trial of its Plasma-Derived Hyperimmune Globuli… https://t.co/5HGIC6Kgl8
March 31st 2021, 4:03pm
SmallCapsDaily @SmallCapsDaily
$KMDA Kamada Announces Top-line Results from its Phase 1/2 Clinical Trial of its Plasma-Derived Hyperimmune Globuli… https://t.co/odnqDaRJp8
March 31st 2021, 4:03pm
MarcJacksonLA @MarcJacksonLA
$KMDA Kamada Announces Top-line Results from its Phase 1/2 Clinical Trial of its Plasma-Derived Hyperimmune Globuli… https://t.co/txlVL6bVAy
March 31st 2021, 2:03pm
IOInvestors @IOInvestors
$KMDA +1.8% (reports Phase 1/2 anti-SARS-CoV-2 plasma-derived hyperimmune globulin treatment for COVID-19) https://t.co/9RdZ9bzCUp
March 31st 2021, 1:03pm
Gamma_Monkey @Gamma_Monkey
Kamada Reports Top-line Data Of Plasma-Derived IgG Treatment From Early-Stage COVID-19 Trial $KMDA https://t.co/GmMNtF8I0o via @benzinga
March 31st 2021, 12:03pm
James__BondOO7 @James__BondOO7
$KMDA results from a phase 1/2 study of its plasma-derived investigational treatment for COVID-19 has shown that t… https://t.co/gBVZpt39gn
March 31st 2021, 12:03pm
FearLessTraDeRx @FearLessTraDeRx
$KMDA Kamada Announces Top-line Results from its Phase 1/2 Clinical Trial of its Plasma-Derived Hyperimmune Globul… https://t.co/ZuqivTQMiz
March 31st 2021, 10:03am
newsfilterio @newsfilterio
Kamada reports top-line results from mid-stage IgG trial in COVID-19 $KMDA https://t.co/mLODD8IMtn
March 31st 2021, 10:03am
Luckinvest17 @Luckinvest17
$KMDA Kamada Announces Top-line Results From Phase 1/2 Clinical Trial Of Plasma-Derived Hyperimmune Globulin Treatment For COVID-19
March 31st 2021, 10:03am
EdgarInsider @EdgarInsider
Filing for 6-K has been made with the SEC: $KMDA #Kamada Ltd https://t.co/l3Tn8IS7l5
March 31st 2021, 10:03am
Beeken_health @Beeken_health
$KMDA - Kamada Announces Top-line Results from its Phase 1/2 Clinical Trial of its Plasma-Derived Hyperimmune Globu… https://t.co/kwefW270nE
March 31st 2021, 10:03am
StckPro @StckPro
$KMDA NEW ARTICLE : Kamada Announces Top-line Results from its Phase 1/2 Clinical Trial of its Plasma-Derived Hyper… https://t.co/9guYWSuOFN
March 31st 2021, 10:03am
stock_titan @stock_titan
$KMDA Kamada Announces Top-line Results from its Phase 1/2 Clinical Trial of its Plasma-Derived Hyperimmune Globuli… https://t.co/I9DYfBBZL4
March 31st 2021, 10:03am
MarcJacksonLA @MarcJacksonLA
$KMDA Kamada to Present at the Jefferies Global Plasma Summit https://t.co/8db6TAGk8K
March 9th 2021, 4:03pm
SmallCapsDaily @SmallCapsDaily
$KMDA Kamada to Present at the Jefferies Global Plasma Summit GlobeNewswire https://t.co/l9UuEcgH7J #smallcapsdaily… https://t.co/Tie1BupuOn
March 9th 2021, 4:03pm
StckPro @StckPro
$KMDA NEW ARTICLE : Kamada to Present at the Jefferies Global Plasma Summit https://t.co/2EH8hvRFJg Get all the lat… https://t.co/Ve909KpCOC
March 9th 2021, 12:03pm
EdgarInsider @EdgarInsider
Filing for 6-K has been made with the SEC: $KMDA #Kamada Ltd https://t.co/nohQJXhxm1
March 9th 2021, 12:03pm
FlashAlert_me @FlashAlert_me
$KMDA [15s. delayed] filed form 6-K on March 09, 07:00:09 https://t.co/lofxps9jKP
March 9th 2021, 12:03pm
StockNewsNow @StockNewsNow
$KMDA Kamada Announces the Closing of the Acquisition of the FDA-Licensed Plasma Collection Center from Blood and P… https://t.co/VCvs207e2L
March 3rd 2021, 7:03pm
MarcJacksonLA @MarcJacksonLA
$KMDA Kamada Announces the Closing of the Acquisition of the FDA-Licensed Plasma Collection Center from Blood and P… https://t.co/ERQbxIhxaL
March 3rd 2021, 4:03pm
SmallCapsDaily @SmallCapsDaily
$KMDA Kamada Announces the Closing of the Acquisition of the FDA-Licensed Plasma Collection Center from Blood and P… https://t.co/iprl7EAkMA
March 3rd 2021, 4:03pm
otcdynamics @otcdynamics
$KMDA Kamada Announces the Closing of the Acquisition of the FDA-Licensed Plasma Collection Center from Blood and P… https://t.co/HOjTD5WO7f
March 3rd 2021, 12:03pm
sbwcws @sbwcws
Kamada closes aquisition of FDA-licensed plasma collection center $KMDA
March 3rd 2021, 12:03pm
StckPro @StckPro
$KMDA NEW ARTICLE : Kamada Announces the Closing of the Acquisition of the FDA-Licensed Plasma Collection Center fr… https://t.co/q6OnHC4Ts0
March 3rd 2021, 12:03pm
EdgarInsider @EdgarInsider
SEC Form 6-K filed by $KMDA #Kamada Ltd https://t.co/ktmeSR5qcV
March 3rd 2021, 12:03pm
bthefirsttoknow @bthefirsttoknow
$KMDA.TA $KMDA Kamada Announces the Closing of the Acquisition of the FDA-Licensed Plasma Collection Center from Bl… https://t.co/RfvGtD7K8U
March 3rd 2021, 12:03pm
FlashAlert_me @FlashAlert_me
$KMDA [15s. delayed] filed form 6-K on March 03, 07:00:48 https://t.co/6FEpSTzCs5
March 3rd 2021, 12:03pm
Peppons3 @Peppons3
$KMDA Kamada Announces the Closing of the Acquisition of the FDA-Licensed Plasma Collection Center from Blood and P… https://t.co/e3nRl4m17o
March 3rd 2021, 12:03pm
StockNewsNow @StockNewsNow
$KMDA Kamada Files Annual Report for the Year Ended December 31, 2020 https://t.co/gmU4kajv2c
February 24th 2021, 9:02pm
SmallCapsDaily @SmallCapsDaily
$KMDA Kamada Files Annual Report for the Year Ended December 31, 2020 GlobeNewswire https://t.co/mGTw1z8nQS… https://t.co/Z7hJvzHWeY
February 24th 2021, 4:02pm
MarcJacksonLA @MarcJacksonLA
$KMDA Kamada Files Annual Report for the Year Ended December 31, 2020 https://t.co/Rdu1DMQX7S
February 24th 2021, 3:02pm
EdgarInsider @EdgarInsider
A Form 6-K filing has been made with the SEC: $KMDA #Kamada Ltd https://t.co/rYdgOHt1cp
February 24th 2021, 12:02pm
ZeContrarian7 @ZeContrarian7
@Kodeshzuela Out of ALTG $KMDA holding took some profits $MDWD holding took some profits
February 18th 2021, 9:02pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2021. All rights reserved.